13F
中

INO INOVIO PHARMACEUTICALS INC

2026Q1 · CUSIP 45773H409 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
99
Δ holders QoQ
-3
Breadth percentile
Top 73%
Whale holders
43
Δ whales
0
Inst. holding value
$55M
New positions
17
Closed positions
20
Price momentum (1Q)
—
Put / Call
3/5

Breadth history (34 quarters)

2024Q1: Δ+81 · h=87 2024Q2: Δ+10 · h=97 2024Q3: Δ+2 · h=99 2024Q4: Δ+7 · h=106 2025Q1: Δ+3 · h=109 2025Q2: Δ-5 · h=104 2025Q3: Δ-4 · h=100 2025Q4: Δ+2 · h=102 2026Q1: Δ-3 · h=99 2024Q1: holders=87 2024Q2: holders=97 2024Q3: holders=99 2024Q4: holders=106 2025Q1: holders=109 2025Q2: holders=104 2025Q3: holders=100 2025Q4: holders=102 2026Q1: holders=99 -81 -40.5 +0 +40.5 +81 7897115 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q1 Top 2% — —

Options Sentiment

Put holders
3
QoQ: +1
Call holders
5
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.58
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-100.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1M 2022-09-30: $9M 2022-12-31: $0M 2023-03-31: $0M 2023-06-30: $0M 2023-09-30: $0M 2023-12-31: $0M 2024-03-31: $0M 2024-06-30: $0M 2024-09-30: $0M 2024-12-31: $0M 2025-03-31: $0M 2025-06-30: $0M 2025-09-30: $0M 2025-12-31: $0M 2026-03-31: $0M 2023-03-31: EPS -1.89 2023-06-30: EPS -1.61 2023-09-30: EPS -1.52 2023-12-31: EPS -1.07 2024-03-31: EPS -1.31 2024-06-30: EPS -1.19 2024-09-30: EPS -0.89 2024-12-31: EPS -0.56 2025-03-31: EPS -0.51 2025-06-30: EPS -0.61 2025-09-30: EPS -0.87 2026-03-31: EPS -0.28 0M 5M 9M $M -2.08 -1.04 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)